|Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer|
MJ Piccart-Gebhart, M Procter, B Leyland-Jones, A Goldhirsch, M Untch, ...
New England Journal of Medicine 353 (16), 1659-1672, 2005
|Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials|
Early Breast Cancer Trialists' Collaborative Group
The Lancet 366 (9503), 2087-2106, 2005
|Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment|
EM Connor, RS Sperling, R Gelber, P Kiselev, G Scott, MJ O'sullivan, ...
New England Journal of Medicine 331 (18), 1173-1180, 1994
|Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011|
A Goldhirsch, WC Wood, AS Coates, RD Gelber, B Thürlimann, HJ Senn
Annals of oncology 22 (8), 1736-1747, 2011
|Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013|
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
|2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial|
I Smith, M Procter, RD Gelber, S Guillaume, A Feyereislova, M Dowsett, ...
The lancet 369 (9555), 29-36, 2007
|Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009|
A Goldhirsch, JN Ingle, RD Gelber, AS Coates, B Thürlimann, HJ Senn
Annals of oncology 20 (8), 1319-1329, 2009
|Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015|
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
|Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood|
SE Lipshultz, SD Colan, RD Gelber, AR Perez-Atayde, SE Sallan, ...
New England Journal of Medicine 324 (12), 808-815, 1991
|Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005|
A Goldhirsch, JH Glick, RD Gelber, AS Coates, B Thürlimann, HJ Senn, ...
Annals of oncology 16 (10), 1569-1583, 2005
|Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial|
J Baselga, I Bradbury, H Eidtmann, S Di Cosimo, E De Azambuja, C Aura, ...
The Lancet 379 (9816), 633-640, 2012
|Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007|
A Goldhirsch, WC Wood, RD Gelber, AS Coates, B Thürlimann, HJ Senn, ...
Annals of oncology 18 (7), 1133-1144, 2007
|The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group|
B Borgelt, R Gelber, S Kramer, LW Brady, CH Chang, LW Davis, ...
International Journal of Radiation Oncology* Biology* Physics 6 (1), 1-9, 1980
|Analysis of survival by tumor response|
JR Anderson, KC Cain, RD Gelber
J Clin Oncol 1 (11), 710-719, 1983
|American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor–positive …|
EP Winer, C Hudis, HJ Burstein, AC Wolff, KI Pritchard, JN Ingle, ...
Journal of clinical oncology 23 (3), 619-629, 2005
|Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98|
AS Coates, A Keshaviah, B Thurlimann, H Mouridsen, L Mauriac, ...
Journal of clinical oncology 25 (5), 486-492, 2007
|Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.|
BA Gusterson, RD Gelber, A Goldhirsch, KN Price, J Säve-Söderborgh, ...
Journal of Clinical Oncology 10 (7), 1049-1056, 1992
|Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant|
RS Sperling, DE Shapiro, RW Coombs, JA Todd, SA Herman, ...
New England Journal of Medicine 335 (22), 1621-1629, 1996
|Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.|
M Smith, D Arthur, B Camitta, AJ Carroll, W Crist, P Gaynon, R Gelber, ...
Journal of Clinical Oncology 14 (1), 18-24, 1996
|Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer|
A Goldhirsch, WC Wood, RD Gelber, AS Coates, B Thurlimann, HJ Senn
Journal of clinical oncology 21 (17), 3357-3365, 2003